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Deletion mutants of the two sortase genes of Enterococcus faecalis OG1RF were constructed. srtC (renamed
here bps for biofilm and pilus-associated sortase) was previously shown to be necessary for the production of
Ebp pili and important for biofilm formation and endocarditis. Here, we report that a srtA deletion mutant
showed a small (5%) yet significant (P  0.037) reduction in biofilm relative to OG1RF, while a srtA bps
double mutant showed a much greater reduction (74% versus OG1RF and 44% versus the bps mutant). In a
murine urinary tract infection (UTI), the 50% infective doses of both the srtA bps and bps mutants were
2 log10 greater than that of OG1RF or the srtA mutant. Similarly, 2 log10 fewer bacteria were recovered
from the kidneys after infection with the bps mutant (P  0.017) and the srtA bps double mutant (P 
0.022) compared to wild-type strain OG1RF. In a competition UTI, the bps mutant was slightly, but not
significantly, less attenuated than the srtA bps double mutant. Fluorescence-activated cell sorter analysis
with Ebp-specific antibodies confirmed that a minority of OG1RF cells express Ebp pili on their surface in vitro
and that Bps has a major role in Ebp pilus biogenesis but also indicated a function for SrtA in surface
localization of the pilus subunit protein EbpA. In conclusion, deletion of bps had a major effect on virulence
in murine UTIs, as well as biofilm; deletion of srtA from OG1RF had little effect on these phenotypes, but its
deletion from a bps mutant had a pronounced effect on biofilm, suggesting that Bps and/or the proteins it
anchors may compensate for the loss of some SrtA function(s).
In gram-positive bacteria, it has been known for some time
that cell surface proteins can be covalently attached to pepti-
doglycan by a mechanism that requires sortase(s) (7, 15, 24).
Sortases are extracellular transpeptidases that are found in the
plasma membrane and have been shown to sort and anchor
proteins that are destined for the cell surface by cleaving the
conserved threonine of C-terminal LPXTG-like motifs, fol-
lowed by amide bond formation between threonine and the
pentaglycine cross-bridge of cell wall peptidoglycan (7, 24).
Sortases can be divided into four classes, namely, A, B, C, and
D, based on their structure (1). Class A sortases, which appear
to be ubiquitous in many gram-positive bacteria, anchor a large
number and broad range of surface proteins (7). The sortase C
class of enzymes are predicted to anchor a much smaller set of
substrates, and the genes coding for these are typically clus-
tered with the substrate genes and have been shown to be
involved in pilus biogenesis in addition to surface anchoring
(18, 22). Genome analysis of Enterococcus faecalis V583 re-
vealed the presence of two class A sortases (EF_2524 and SrtA
[EF_3056]), one class C sortase (SrtC [EF_0194], renamed
here Bps for biofilm and pilus-associated sortase) (1, 16), and
41 surface proteins bearing a cell wall sorting signal motif (19).
It is believed that at least some of these surface proteins are
microbial surface components recognizing adhesive matrix
molecules (19) that play a role in the attachment of E. faecalis
to extracellular matrix proteins and thus are likely to be im-
portant for virulence; one example is Ace, an E. faecalis adhe-
sin to collagen and laminin (11). In addition, two other sorta-
ses, named srt-1 and srt-2, were reported in E. faecalis strain
E99 containing a bee (biofilm enhancer in enterococcus) locus;
however, their occurrence was rare and they were found in
only 2 of 40 E. faecalis isolates tested (23).
While analyses of sortase mutants of several gram-positive
pathogens have provided evidence for their wide range of roles
in bacterial physiology and pathogenesis (reviewed in refer-
ence 7), only limited information is available on the role of E.
faecalis sortases. A study by Kristich et al. (5) demonstrated
that SrtA anchors the plasmid-encoded protein Asc10 to the
enterococcal cell wall to facilitate the pheromone-induced ag-
gregation of E. faecalis OG1RF cells. Deletions of bee locus-
linked srt-1 and srt-2 of E. faecalis E99 (23) and of the ubiqui-
tous ebp (endocarditis and biofilm-associated pilus)-linked
sortase C (encoded by bps, also referred to in earlier studies as
srtC) of E. faecalis OG1RF (13) have each led to a reduction in
biofilm production. It was also demonstrated that bps, but not
srtA, was essential for tethering of the endocarditis-associated
Ebp pili by E. faecalis OG1RF. However, what other proteins
may be processed by Bps or SrtA and what role these sortases
may play in virulence have not been reported.
The present study further explored the role of E. faecalis
sortases by deleting independently or in combination the two
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sortase genes (namely, srtA and bps) present in E. faecalis
strain OG1RF. Here, we generated sortase (srtA with and
without bps) deletion derivatives of OG1RF and evaluated
these constructs for their phenotypic effects by using biofilm
assays and a mouse urinary tract infection (UTI) model and for
their effect on the surface localization of Ebp pilus subunit
proteins.
MATERIALS AND METHODS
Bacterial strains and media. The bacterial strains and plasmids used in this
study are listed in Table 1. A total of 100 E. faecalis strains isolated over 32 years
from diverse locations (the United States, Thailand, China, Argentina, Spain,
Canada, Belgium, and the United Kingdom), including clinical isolates, nosoco-
mial and community-derived fecal isolates, and animal isolates, were included.
Tryptic soy broth (Difco Laboratories, Sparks, MD) containing 0.25 M glucose
was used for biofilm experiments. Brain heart infusion broth (BHIB) (Difco
Laboratories) and/or brain heart infusion agar (BHIA) was used for routine
culturing of bacteria. BHIB containing 40% heat-inactivated horse serum (BHIS;
Sigma, St. Louis, MO) was used to culture the bacteria for in vivo experiments.
The antibiotics (Sigma) used in BHIA plates for the growth of OG1RF and the
various mutant strains were erythromycin (10 g/ml), fusidic acid (25 g/ml),
rifampin (100 g/ml), and spectinomycin (1,000 g/ml).
General techniques. Genomic DNA was extracted by the hexadecyltrimethyl-
ammonium bromide method as described previously (25). For the PCR primers
used for amplification and sequencing, see Table S1 in the supplemental mate-
rial. Pulsed-field gel electrophoresis was carried out as described earlier (9).
Southern and colony lysate hybridizations were performed under high-stringency
conditions (20) with probes labeled with the RadPrime DNA labeling system
(Invitrogen).
Construction of sortase mutants. Nonpolar deletion mutants of E. faecalis
were constructed by allelic replacement (4, 13). By crossover PCR, fragments
upstream (1 kb) and downstream (900 bp) of the complete srtA open reading
frame were amplified together to create a single 1.9-kb fragment with primers
listed elsewhere (see Table S1 in the supplemental material). After ligating this
fragment into pCJK47 (4), the construct was then transformed into Escherichia
coli EC1000 (6) cells to obtain TX5497 (Table 1). After confirming the sequence,
the plasmid containing the srtA up-down fragment (pTEX5497) was electropo-
rated into E. faecalis CK111 competent cells (5). CK111 cells containing
pTEX5497 were conjugated with wild-type OG1RF and TX5470 by a standard
technique (12), and single-crossover integrants (OG1RF::pTEX5497 and
TX5470::pTEX5497) were selected on BHIA plates which contained rifampin
(100 g/ml) with erythromycin (10 g/ml) or spectinomycin (1,000 g/ml). Single
colonies were purified on BHIA plates with fusidic acid (25 g/ml) with eryth-
romycin (10 g/ml) and subjected to the PheS* counterselection (negative se-
lection) system with MM9YEG agar plates supplemented with 10 mM p-Cl-Phe
(4) to select for double-crossover deletions. The deletions were confirmed as
correct by PCR sequencing, hybridization, and pulsed-field gel electrophoresis
procedures.
Growth curve experiment. Cultures of test bacteria grown overnight were
diluted (1:20) in BHIS and grown at 37°C with gentle shaking. A reading of
optical density at 600 nm (OD600) was taken every hour from 0 to 12 h and then
at 24 h. At intervals of 0, 4, and 6 h, CFU counts were also determined by plating
serial dilutions on BHIA.
Biofilm assay. A biofilm density assay was carried out for wild-type E. faecalis
OG1RF and its isogenic srtA, bps, and srtA bps deletion mutants according
to a method previously described by Mohamed et al. (8).
UTI model. Protocols for preparation of mice, inoculum volumes, and all
others stages of the experiment were the same ones previously used in our
laboratory (21). Initially groups of five mice per inoculum (102 to 106 CFU) were
used for each test bacterial strain (wild-type OG1RF and the srtA, bps, and
srtA bps mutants), resulting in several independent monoinfection experi-
ments. In the second set of monoinfection experiments, groups of 10 additional
mice were infected with an inoculum of 104 CFU. The urinary bladders and
kidney pairs were excised, weighed, and homogenized in 1 ml and 5 ml of saline,
respectively, and dilutions were plated onto BHIA for CFU counting. The 50%
infective dose (ID50) of each test bacterium was determined by a previously
described method (17). The detection limit of bacteria in this experiment was 10
CFU/ml of tissue homogenate. Identities of the test bacteria recovered from
infected organs were confirmed by plating them on bile esculin azide agar plates
(Difco Laboratories) and BHIA plates with rifampin (100 g/ml) or by colony
PCR. For the competition assay, cultures of bps and srtA bps mutants were
resuspended in saline solution and mixed in approximately equal (1:1) volumes
based on OD600 readings, used to infect mice, and plated for colony counts. After
24 h, CFU were recovered from organs as previously described (21). Colony
lysate preparations were probed with intragenic bps, srtA (amplified with primer
sets EF3056F-EF3056R for srtA and EF1094F-EF1094R for bps), and ace (2)
probes, and high-stringency hybridization techniques were used to determine the
ratio of bps mutant to srtA bps double mutant cells in the bacterial colonies
recovered. Similar to the method previously described for E. faecalis mixed
infections (13, 14), the mean virulence index of srtA bps mutants relative to
that of bps mutants was calculated with the following equation: Mean virulence
index  [(% bps in inoculum)/(% srtA bps in inoculum)]/[(% bps in
kidneys)/(% srtA bps in kidneys)].
The University of Texas Health Science Center at Houston preapproved
protocol and guidelines of the Animal Welfare Committee were followed
throughout the course of this study.
Polyclonal antibodies and flow cytometry. Production and purification of poly-
clonal antibodies against recombinant EbpA, EbpB, and EbpC proteins were
described elsewhere (13). For flow cytometry analysis of surface expression of
Ebp proteins, bacteria were grown in BHIS to late log phase. After being washed
twice with phosphate-buffered saline (PBS), 100 l of bacteria adjusted to an
OD600 of 0.2 were suspended in 40 l of newborn calf serum (Sigma) and
incubated for 15 min at room temperature. After centrifugation at 10,000 g for
6 min, 100 l of 20 g/ml preimmune or affinity-purified anti-Ebp specific
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristicsa Reference or source
E. faecalis strains
OG1RF Laboratory strain; Rifr Fusr 10
CK111(pCF10) Conjugative donor construct; Rifs Fuss Sper 5
TX5470 bps deletion mutant of OG1RF; OG1RF bpsb 13
TX5536 srtA deletion mutant of OG1RF; OG1RF srtA This study
TX5537 srtA and bps double-deletion mutant of OG1RF; OG1RF srtA bps This study
E. coli strains
EC1000 E. coli host strain for routine cloning of RepA-dependent plasmids 6
TX5497 EC1000(pTEX5497); Chlr Eryr This study
Plasmids
pCJK47 Plasmid for markerless exchange; carries oriTpCF10, lacZ, and P-pheS*; Ery
r 4
pTEX5497 Plasmid for srtA deletion with flanking regions of srtA cloned into pCJK47; Eryr This study
a Abbreviations: Chl, chloramphenicol; Ery, erythromycin; Fus, fusidic acid; Gen, gentamicin; Rif, rifampin; Tet, tetracycline; Spe, spectinomycin. A superscript s
designates sensitivity, and a superscript r designates resistance.
b Previous studies referred to bps as srtC.
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antibodies in dilution buffer (PBS containing 20% newborn calf serum and 0.1%
bovine serum albumin [BSA]) was added and the solution was incubated at 4°C
for 2 h. The bacteria were washed twice with 400 l of 0.1% BSA in PBS and
then added to a dilution buffer containing 100 l of 1:100-diluted goat anti-rabbit
immunoglobulin G (IgG) conjugated with F(ab)2 fragment-specific R-phyco-
erythrin (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) and
incubated at 4°C for 2 h. After cells were washed three times with 400 l of 0.1%
BSA in PBS, cells were resuspended in 500 l of 1% paraformaldehyde in PBS
and analyzed with a Coulter EPICS XL AB6064 flow cytometer (Beckman
Coulter, Fullerton, CA) and System II software.
Statistics. Differences in OD570 readings in biofilm experiments were evalu-
ated with the Kruskal-Wallis test (analysis of variance [ANOVA]) and, in some
cases, also by the Mann-Whitney test. Differences in the log10 CFU of bacteria
recovered from organs in monoinfections with inocula of 104 CFU were evalu-
ated by the unpaired t test. Differences between the total numbers of infected
kidney pairs/bladder (102 to 106 CFU inoculum groups combined) were evalu-
ated by Fisher’s exact test. The percentages of the bps mutant in the inoculum
versus the percentages of the bps mutant in the kidneys of individual mice
infected with the bps and srtA bps mutants in the competition assay were
analyzed for significance by the paired t test.
RESULTS AND DISCUSSION
An estimated 8 million doctor visits in the United States are
linked with UTIs each year (3). Although the significance of E.
faecalis in causing infections associated with the kidney and
bladder is well documented (accounting for 2 to 12% of out-
patient UTIs and 7 to 16% of inpatient UTIs) (26), little is
known about the factors used by E. faecalis to infect this site.
To help develop therapeutic or preventive measures against E.
faecalis UTIs, it is important to identify E. faecalis surface
antigens which function as adhesins to urinary tract tissues.
Cell wall-associated proteins of E. faecalis are the focus of our
ongoing research because of their predicted central role in
adhesion and, presumably, colonization of tissues (e.g., heart
valves and kidneys) and infections (e.g., endocarditis and
UTIs). Since these surface proteins are thought to utilize the
sortase-mediated cell wall anchoring mechanism, we here con-
structed and analyzed different sortase mutants to indirectly
assess the global effect of surface-associated proteins in biofilm
formation and pathogenicity of E. faecalis in UTIs. Conceptu-
ally, we consider the sortases to be fitness factors, rather than
virulence factors, since the impact of sortase deletions is pre-
sumably the result of defective localization of a number of cell
wall-associated proteins, including virulence factors.
Sortase-encoding genes of E. faecalis strains. Of the three
sortase genes (srtA, EF_2524, and bps) previously identified in
strain V583 (16), EF_2524 (which is part of an integrated
plasmid remnant region [EF_2512 to EF_2542]) of V583 (16)
was not present in seven of nine E. faecalis strains tested,
including OG1RF (1, 13). Since our previous study found that
bps is ubiquitous in E. faecalis (13), here we tested for the
presence of srtA in 100 diverse E. faecalis strains by colony
hybridization and found that this gene was also present in all of
the isolates tested. The ubiquitous distribution of these two
genes in diverse E. faecalis strains suggests that they are part of
the core genome and have a role in E. faecalis biology. We next
analyzed the almost completed genomic sequence of E. faecalis
strain OG1RF (10) generated by our collaboration with the hu-
man genome sequencing center at the Baylor College of Medi-
cine (available at http://www.hgsc.bcm.tmc.edu/projects/microbial
/microbial-detail.xsp?project_id111) and confirmed that
OG1RF (which failed to hybridize with EF_2524) contains only
the two ubiquitous sortase genes srtA and bps. In order to evaluate
the independent roles of these sortase genes, we generated sor-
tase (srtA and/or bps) deletion derivatives of strain OG1RF.
Deletion of E. faecalis srtA from OG1RF and from its bps
deletion mutant, TX5470. Sequencing of OG1RF srtA
(TX5536) and OG1RF srtA bps (TX5537) confirmed the
deletion of the complete srtA open reading frame, which en-
codes 244 amino acids (data not shown). There were no obvi-
ous differences in the growth patterns of wild-type E. faecalis
OG1RF and its isogenic sortase mutants (srtA, bps, and
srtA bps), suggesting that the sortases are not essential for in
vitro growth of E. faecalis.
Contribution of the srtA and bps genes to biofilm formation.
All of the sortase mutant derivatives of E. faecalis OG1RF
showed decreased biofilm formation (P 	 0.0001 by Kruskal-
Wallis test), with reductions ranging from 5% (srtA mutant;
median OD570  0.893; interquartile range [IQR], 0.841 to
0.968) to 74% (srtA bps double mutant; median OD570 
0.247; IQR, 0.204 to 0.274) relative to wild-type E. faecalis
OG1RF (median OD570  0.943; IQR, 0.887 to 1.004) (Fig. 1).
The decrease for the srtA mutant was small and not signifi-
cant (P 
 0.05) by post-hoc test of Kruskal-Wallis ANOVA
testing compared to OG1RF, although it was significant by the
Mann Whitney test (Fig. 1) (P  0.037), and observed in
repeated experiments. The decrease seen with the srtA bps
double mutant (see above) was much more substantial, with
the median OD570 of srtA bps 44% less than that of bps
(median OD570  0.441; IQR, 0.396 to 0.516; P 	 0.001); the
results for bps are consistent with those previously reported
(13). This surprising and pronounced decrease seen with the
srtA bps double mutant versus the bps mutant suggests the
possibilities that (i) Bps may compensate for the loss of SrtA
from OG1RF and that (ii) in the absence of Bps, SrtA per-
forms some function that is important for biofilm formation.
Effect of srtA and bps gene deletions in a murine UTI model.
In a recent study, we established a murine UTI model with
OG1RF grown in BHIS and showed that Ebp pili are impor-
tant for this strain’s ability to cause infection of murine kidneys
FIG. 1. Comparison of biofilm production of wild-type OG1RF
and the TX5536 (srtA), TX5470 (bps), and TX5537 (srtA bps)
mutants. Median values and interquartile ranges are shown. Multiple
comparison of median OD570s from biofilm assays of wild-type and
mutant cells by Kruskal-Wallis test (ANOVA) with Dunn’s post-hoc
modification showed a highly significant difference (P 	 0.0001). In-
dividual median OD570s from biofilm assays of wild-type and mutant
cells were compared by Mann-Whitney test and are shown above the
whiskers.
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(21). Here, to test the effects of different sortase deletion
mutant derivatives of OG1RF, mice were infected as previ-
ously described (21) via intraurethral catheterization with a
range of CFU. The ID50s derived from monoinfection exper-
iments showed that both the srtA bps (ID50  1.5  10
4)
and bps (ID50  3.6  10
4) mutants required 2 log10 more
cells to infect 50% of the mice than did wild-type E. faecalis
OG1RF (ID50  1.1  10
2) or srtA (ID50  1.4  10
2),
indicating a substantial role for Bps compared to SrtA in UTI
infections. Furthermore, the comparable (2 log) difference
between the ID50s of the bps mutant and that of strain OG1RF
versus those of the previously reported ebp mutant and strain
OG1RF (21) suggests that the effect seen after bps deletion is
likely due to the resulting inability to form Ebp pili (13). For
the total number of mouse kidneys and urinary bladders in-
fected by the mutants compared to the number infected by
wild-type E. faecalis OG1RF, see Table S2 in the supplemental
material. The percentage of kidneys of mice infected summed
across all inocula was 91% for wild-type OG1RF, 80% for the
srtA mutant (P  0.2650), 63% for the bps mutant (P 
0.0048), and 51% for the srtA bps double mutant (P 	
0.0001). Although fewer bladders than kidneys were infected,
the differences between individual strains were similar to those
of kidney infections (see Table S2 in the supplemental mate-
rial); the percentage of bladders of mice infected summed
across all inocula was 78% for wild-type OG1RF, 76% for the
srtA mutant (P 1.0), 51% for the bps mutant (P 0.0177),
and 37% for the srtA bps double mutant (P  0.0005).
The log10 CFU recovered from the kidney pairs (n  15) of
mice infected with wild-type E. faecalis OG1RF and its iso-
genic mutants at a 104 CFU inoculum are shown in Fig. 2. A
comparison of the mean log10 CFU of bacteria recovered
from the kidneys showed that the differences between OG1RF
and the bps mutant (2.1  0.8 log10) and between OG1RF
and the srtA bps double mutant (2.1  0.8 log10) were
statistically significant (P  0.017 and P  0.022, respectively),
while the difference between OG1RF and the srtA mutant
(0.9  0.9, P  0.280) was not.
Because the results shown above for the percentage of mice
infected, although not significant by Fisher’s test (see Table S2
in the supplemental material), suggested that the srtA bps
double mutant may be more attenuated than the bps mutant,
we next used a competition assay with an approximately equal
mixture of bps and srtA bps mutant cells of two different
inocula. For 17 animals, the percentage of bps mutant cells in
the total inoculum was 42% to 43%. At autopsy, the percent-
ages of bps mutant cells in the total number of CFU recov-
ered from kidneys were in the range of 52 to 63% for five
animals and 92%, 46%, and 23% for one animal each. Nine
animals were not infected. The mean percentage of bps mu-
tant cells in the total number of CFU of bacteria recovered
from kidneys was 55.1%, demonstrating a slight outnumbering
by the bps mutant; however, the paired t test showed no
significant difference between these mutants (P 0.1097). The
mean virulence index (13, 14) of the srtA bps double mutant
relative to the bps mutant in kidneys was 0.605, indicating
that SrtA plays only a minor role in UTI or that Bps can
compensate for the SrtA loss. Taken together, our bps mutant
FIG. 2. Monoinfection with wild-type E. faecalis OG1RF and its isogenic mutants. Data are from 15 mice infected with 104 CFU; results are
expressed as log10 CFU per gram from kidney homogenates 48 h after transurethral challenge. The log10 CFU from both kidneys were combined
and averaged. A value of 1 was assigned to those kidneys with 0 CFU. Triangles represent wild-type E. faecalis OG1RF, circles represent OG1RF
srtA, diamonds represent OG1RF bps, and squares represent OG1RF srtA bps. Horizontal bars represent the geometric mean. The mean
difference in CFU counts of sortase mutants versus OG1RF is given as the log10  the standard deviation (SD). Differences in the log10 CFU of
OG1RF versus the srtA, bps, and srtA bps mutants recovered from organs were evaluated by the unpaired t test.
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data corroborate the previously demonstrated role of Ebp pili
(21) in murine kidney infections and the competition assay
results suggest little to no additional role for SrtA in this
model. This is in contrast to the role of SrtA in other gram-
positive organisms, such as Staphylococcus aureus and Listeria
monocytogenes, where SrtA plays a much larger role in viru-
lence (7). However, it is possible that srtA of E. faecalis con-
tributes more significantly to the UTI disease process in hu-
mans compared to mice or it may be more important for other
infection processes such as endocarditis.
Role of sortases in surface localization and polymerization
of Ebp pili. By Western blotting, we have previously shown that
bps, but not srtA, is needed for polymerization of Ebp pili (13)
and immunogold electron microscopy estimated that few wild-
type cells (	2% of cells grown in BHIB and 	20% of cells
grown in tryptic soy broth–0.25 M glucose) produce Ebp pili in
vitro (13). Here, we measured the surface-localized Ebp pro-
teins of wild-type OG1RF and sortase mutants after growth in
BHIS (the growth condition that enhanced levels of high-
molecular-weight Ebp bands in Western blot assays) (13) by
fluorescence-activated cell sorting analysis. While anti-Ace an-
tibodies (used as a positive control) bound 98% of wild-type
OG1RF grown at 46°C (11) (data not shown), the percentages
of EbpA-, EbpB-, and EbpC-expressing cells in BHIS cultures
of strain OG1RF were 34%, 20%, and 24%, respectively (Fig.
3) and the mean fluorescence intensities of EbpA, EbpB, and
EbpC were 29.8, 2.4, and 27.1, respectively. The relatively low
intensity of EbpB observed in flow cytometry analysis seemed
to contradict the immunoblotting data from our earlier study
(13), which showed that the EbpB protein is part of the poly-
meric structure. One possible explanation for these results is
that EbpB may be relatively hidden beneath the surface of the
Ebp pilus structure and thus not accessible to antibodies in a
flow cytometry analysis, as seen with group B streptococci (22).
The percentages of bps mutant cells with surface-localized
EbpA, EbpB, and EbpC were 28%, 8%, and 10%, but with
much lower mean fluorescence intensities (2.1, 3.0, and 2.0,
respectively) (Fig. 3). This markedly reduced fluorescence in-
tensity of Ebp proteins in the bps mutant is consistent with
the role of Bps in pilus polymerization, and this observation is
consistent with loss of Ebp high-molecular-weight multimers in
Western blot assays of the bps mutant (13). Since our earlier
EbpA surface localization studies by immunogold electron mi-
croscopy (13) showed staining of both the cell surface and the
pili of wild-type OG1RF, the persistence of a relatively high
percentage of EbpA-positive bps mutant cells (28%), but with
a greatly reduced mean fluorescence intensity (29.8 to 2.1),
suggests that the EbpA subunit protein is still located on the
cell surface of the bps mutant, presumably in the monomeric
form. Unlike the bps mutant, the srtA mutant (TX5536)
showed an expression pattern similar to that of wild-type
OG1RF, albeit with higher mean fluorescence intensities (49.7,
FIG. 3. Flow cytometry analysis of surface expression of Ebp pilus proteins in wild-type E. faecalis OG1RF and its isogenic mutants. Cells were
incubated with either control preimmune (PI) IgGs or anti-Ebp specific IgGs, followed by incubation with a F(ab)2 fragment of goat anti-rabbit
IgGs (heavy plus light chains) conjugated to R-phycoerythrin. Bacteria were analyzed by flow cytometry by using side scatter as the threshold of
detection. Specific binding by anti-Ebp antibodies is indicated as log fluorescence intensity on the x axis, and each histogram represent 50,000
bacteria.
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3.3, and 34.3 for EbpA, EbpB, and EbpC, respectively) and
some difference in the percentage of cells, with a small de-
crease for EbpA (34 versus 27%) and small increases for EbpB
(20 versus 26%) and EbpC (24 versus 26%) (Fig. 3). These
moderately increased Ebp intensities with the srtA mutant,
implying enhanced pilus production compared to that of the
wild type, suggest that the presence of SrtA somehow results in
interference with the action of Bps for polymerization. The
mutant that lacked both sortases (TX5537) showed the least
surface localization (6%, 3%, and 5% of cells with mean flu-
orescence intensities of 1.8, 2.4, and 2.4 for EbpA, EbpB, and
EbpC, respectively) (Fig. 3). The decrease in the percentage of
EbpA-stained cells of the srtA bps double mutant (6%)
compared to the bps mutant (28%) indicates that SrtA may
be involved in the surface anchoring of EbpA, at least in the
absence of Bps; an additional decrease was also seen to a
minor degree with both EbpB and EbpC. Taken together,
these surface analysis studies indicate that both sortases are
important for Ebp component surface localization in OG1RF,
with Bps being the major one for pilus biogenesis, as well as for
ascending murine UTI.
In summary, from this study and the previous work from our
laboratory (13, 21), it appears likely that Bps, presumably via
Bps-anchored surface proteins, plays an important role in both
in vitro biofilm formation and in vivo murine kidney infections
under the conditions tested. The results from this study also
provide evidence for an additional role of SrtA or SrtA-an-
chored surface proteins in biofilm, particularly in the absence
of Bps, but a minor role in UTI. Flow cytometry studies have
shown that both sortases are important for Ebp pilus compo-
nent surface localization in OG1RF, with the class C sortase
Bps being the major one for pilus assembly. The ubiquitous
presence of both sortase genes in E. faecalis isolates increases
the likelihood that sortases in general, and Bps in particular,
could be a target for disease prevention.
ACKNOWLEDGMENTS
We thank Karen Jacques-Palaz and Charlene Thomsom for techni-
cal assistance.
This work was supported by NIH grant R37 AI 47923 from the
Division of Microbiology and Infectious Diseases, NIAID, to B. E.
Murray. Kelvin Kemp was supported by NIH grant T35 DK007676
from the National Institute of Diabetes and Digestive and Kidney
Diseases and a Summer Scholarship Award from the Infectious Dis-
eases Society of America.
REFERENCES
1. Dramsi, S., P. Trieu-Cuot, and H. Bierne. 2005. Sorting sortases: a nomen-
clature proposal for the various sortases of Gram-positive bacteria. Res.
Microbiol. 156:289–297.
2. Duh, R. W., K. V. Singh, K. Malathum, and B. E. Murray. 2001. In vitro
activity of 19 antimicrobial agents against enterococci from healthy subjects
and hospitalized patients and use of an ace gene probe from Enterococcus
faecalis for species identification. Microb. Drug Resist. 7:39–46.
3. Foxman, B. 2002. Epidemiology of urinary tract infections: incidence, mor-
bidity, and economic costs. Am. J. Med. 113(Suppl. 1A):5S–13S.
4. Kristich, C. J., J. R. Chandler, and G. M. Dunny. 2007. Development of a
host-genotype-independent counterselectable marker and a high-frequency
conjugative delivery system and their use in genetic analysis of Enterococcus
faecalis. Plasmid 57:131–144.
5. Kristich, C. J., D. A. Manias, and G. M. Dunny. 2005. Development of a
method for markerless genetic exchange in Enterococcus faecalis and its use
in construction of a srtA mutant. Appl. Environ. Microbiol. 71:5837–5849.
6. Leenhouts, K., G. Buist, A. Bolhuis, A. ten Berge, J. Kiel, I. Mierau, M.
Dabrowska, G. Venema, and J. Kok. 1996. A general system for generating
unlabelled gene replacements in bacterial chromosomes. Mol. Gen. Genet.
253:217–224.
7. Marraffini, L. A., A. C. Dedent, and O. Schneewind. 2006. Sortases and the
art of anchoring proteins to the envelopes of gram-positive bacteria. Micro-
biol. Mol. Biol. Rev. 70:192–221.
8. Mohamed, J. A., W. Huang, S. R. Nallapareddy, F. Teng, and B. E. Murray.
2004. Influence of origin of isolates, especially endocarditis isolates, and
various genes on biofilm formation by Enterococcus faecalis. Infect. Immun.
72:3658–3663.
9. Murray, B. E., K. V. Singh, J. D. Heath, B. R. Sharma, and G. M. Weinstock.
1990. Comparison of genomic DNAs of different enterococcal isolates using
restriction endonucleases with infrequent recognition sites. J. Clin. Micro-
biol. 28:2059–2063.
10. Murray, B. E., K. V. Singh, R. P. Ross, J. D. Heath, G. M. Dunny, and G. M.
Weinstock. 1993. Generation of restriction map of Enterococcus faecalis
OG1 and investigation of growth requirements and regions encoding bio-
synthetic function. J. Bacteriol. 175:5216–5223.
11. Nallapareddy, S. R., X. Qin, G. M. Weinstock, M. Hook, and B. E. Murray.
2000. Enterococcus faecalis adhesin, Ace, mediates attachment to extracel-
lular matrix proteins collagen type IV and laminin as well as collagen type I.
Infect. Immun. 68:5218–5224.
12. Nallapareddy, S. R., K. V. Singh, and B. E. Murray. 2006. Construction of
improved temperature-sensitive and mobilizable vectors and their use for
constructing mutations in the adhesin-encoding acm gene of poorly trans-
formable clinical Enterococcus faecium strains. Appl. Environ. Microbiol.
72:334–345.
13. Nallapareddy, S. R., K. V. Singh, J. Sillanpaa, D. A. Garsin, M. Hook, S. L.
Erlandsen, and B. E. Murray. 2006. Endocarditis and biofilm-associated pili
of Enterococcus faecalis. J. Clin. Investig. 116:2799–2807.
14. Nannini, E. C., F. Teng, K. V. Singh, and B. E. Murray. 2005. Decreased
virulence of a gls24 mutant of Enterococcus faecalis OG1RF in an experi-
mental endocarditis model. Infect. Immun. 73:7772–7774.
15. Paterson, G. K., and T. J. Mitchell. 2004. The biology of Gram-positive
sortase enzymes. Trends Microbiol. 12:89–95.
16. Paulsen, I. T., L. Banerjei, G. S. Myers, K. E. Nelson, R. Seshadri, T. D.
Read, D. E. Fouts, J. A. Eisen, S. R. Gill, J. F. Heidelberg, H. Tettelin, R. J.
Dodson, L. Umayam, L. Brinkac, M. Beanan, S. Daugherty, R. T. DeBoy, S.
Durkin, J. Kolonay, R. Madupu, W. Nelson, J. Vamathevan, B. Tran, J.
Upton, T. Hansen, J. Shetty, H. Khouri, T. Utterback, D. Radune, K. A.
Ketchum, B. A. Dougherty, and C. M. Fraser. 2003. Role of mobile DNA in
the evolution of vancomycin-resistant Enterococcus faecalis. Science 299:
2071–2074.
17. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty
percent end points. Am. J. Hyg. 27:493–497.
18. Scott, J. R., and D. Zahner. 2006. Pili with strong attachments: Gram-
positive bacteria do it differently. Mol. Microbiol. 62:320–330.
19. Sillanpaa, J., Y. Xu, S. R. Nallapareddy, B. E. Murray, and M. Hook. 2004.
A family of putative MSCRAMMs from Enterococcus faecalis. Microbiology
150:2069–2078.
20. Singh, K. V., T. M. Coque, G. M. Weinstock, and B. E. Murray. 1998. In vivo
testing of an Enterococcus faecalis efaA mutant and use of efaA homologs for
species identification. FEMS Immunol. Med. Microbiol. 21:323–331.
21. Singh, K. V., S. R. Nallapareddy, and B. E. Murray. 2007. Importance of
endocarditis and biofilm associated pilus (ebp) locus in the pathogenesis of
Enterococcus faecalis ascending urinary tract infection. J. Infect. Dis. 195:
1671–1677.
22. Telford, J. L., M. A. Barocchi, I. Margarit, R. Rappuoli, and G. Grandi.
2006. Pili in gram-positive pathogens. Nat. Rev. Microbiol. 4:509–519.
23. Tendolkar, P. M., A. S. Baghdayan, and N. Shankar. 2006. Putative surface
proteins encoded within a novel transferable locus confer a high-biofilm
phenotype to Enterococcus faecalis. J. Bacteriol. 188:2063–2072.
24. Ton-That, H., L. A. Marraffini, and O. Schneewind. 2004. Protein sorting to
the cell wall envelope of Gram-positive bacteria. Biochim. Biophys. Acta
1694:269–278.
25. Wilson, K. 1994. Preparation of genomic DNA from bacteria, p. 2.4.1–2.4.2.
In F. M. Ausubel, R. Brent, R. E. Kingston, D. M. David, J. G. Scidman, J. A.
Smith, and K. Struhl (ed.), Current protocols in molecular biology. Green
Publishing Associates, Brooklyn, NY.
26. Wilson, M. L., and L. Gaido. 2004. Laboratory diagnosis of urinary tract
infections in adult patients. Clin. Infect. Dis. 38:1150–1158.
Editor: J. N. Weiser
5404 KEMP ET AL. INFECT. IMMUN.
